Frequency of Rare Alpha-1 Antitrypsin Variants in Polish Patients with Chronic Respiratory Disorders

K Duk1, A Zdral1, B Szumna1

  • 1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, 26 Płocka St., 01-138, Warsaw, Poland.

Insights

The PI*Z alpha-1 antitrypsin (A1AT) deficiency allele is more common in Polish patients with chronic respiratory disorders than previously thought. Rare SERPINA1 variants, including PI*F, were also identified, suggesting a higher prevalence than in other European populations.

Area of Science:

  • Genetics
  • Pulmonology
  • Biochemistry

Background:

  • The SERPINA1 gene encodes alpha-1 antitrypsin (A1AT), a protein crucial for protecting lungs from damage.
  • A1AT deficiency, caused by SERPINA1 gene mutations, predisposes individuals to severe chronic respiratory disorders like emphysema and COPD.
  • While PI*S and PI*Z are common deficiency variants, rare SERPINA1 mutations also contribute to respiratory disease.

Purpose of the Study:

  • To determine the frequencies of common and rare SERPINA1 mutations in 1033 Polish patients with chronic respiratory disorders.
  • To compare the prevalence of A1AT deficiency alleles in this patient cohort with the general Polish population and other European studies.

Main Methods:

  • Blood samples from patients diagnosed with A1AT deficiency were analyzed.
  • A1AT serum concentration was measured using nephelometry and immune isoelectric focusing.
  • Genotyping was performed using PCR, with direct sequencing employed for rare variant identification.

Main Results:

  • 86% of patients had the normal PI*MM genotype; 14% carried at least one A1AT deficiency variant.
  • Common deficiency alleles PI*S (2.1%) and PI*Z (10.8%) were identified.
  • Rare variants PI*F (n=5) and PI*I (n=4) were detected in nine patients. PI*M2Obernburg was found in one patient.

Conclusions:

  • The PI*Z A1AT deficiency allele is significantly more prevalent in Polish patients with chronic respiratory disorders than in the general population.
  • The prevalence of the PI*F allele in this cohort appears higher than reported in other European studies.
  • This study highlights the importance of comprehensive SERPINA1 genotyping for diagnosing A1AT deficiency in patients with respiratory conditions.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
66
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K